Hyo-Pyo Lee

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer

Sokbom Kang, Woong Ju, Jae‐Weon Kim et al. · Experimental & Molecular Medicine · 2006 · 92 citations · Full text

Medicine, Genetics, Oncology +17

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer

Hyun Hoon Chung, Mi-Kyung Kim, Jae‐Weon Kim et al. · Gynecologic Oncology · 2006 · 61 citations

Medicine, Genetics, Oncology +12

Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix

Me-Yeon Lee, Hong-Gyun Wu, Kyubo Kim et al. · Gynecologic Oncology · 2006 · 35 citations

Medicine, Oncology, Radiation Oncology +11

Predictive Value of Individualized Tumor Response Testing by ATP-Based Chemotherapy Response Assay in Ovarian Cancer

Seung Su Han, Sung Ho Choi, Yoo‐Kyung Lee et al. · Cancer Investigation · 2008 · 20 citations

Medicine, Oncology, Pharmacology +16

Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer

Kyubo Kim, Eui Kyu Chie, Hong‐Gyun Wu et al. · Gynecologic Oncology · 2005 · 19 citations

Medicine, Oncology, Surgery +14